Legalon (Milk Thistle Dry Extract, Refined And Standardised)

Legalon, a milk‑thistle based herbal hepatoprotective, is used to support liver health across several conditions.

• Hepatoprotection: helps protect liver cells from toxin‑induced damage and supports regeneration of hepatocytes.
• Chronic liver disease: supports overall liver function, may aid in reducing enzyme elevations and improving metabolic balance in conditions such as non‑alcoholic fatty liver disease.
• Alcoholic liver disease: assists in mitigating liver injury associated with chronic alcohol intake, helping to maintain cellular integrity and reduce oxidative stress.

• Milk thistle dry extract contains silymarin, a mixture of flavonolignans that exhibit antioxidant activity, inhibit lipid peroxidation, and stabilize hepatocyte membranes. The constituents enhance protein synthesis in liver cells, promote regeneration, and modulate inflammatory pathways, thereby contributing to hepatoprotection. Additionally, silymarin interferes with the binding of toxins to cellular receptors and may increase the activity of glutathione‑dependent enzymes, further protecting the liver from oxidative injury.

Milk thistle dry extract is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects

• Gastrointestinal discomfort: mild nausea, bloating or abdominal pain.
• Headache: transient mild headache reported in some individuals.
• Allergic skin reaction: occasional rash or pruritus at the site of contact.

Serious or Rare Side Effects

• Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention.
• Hepatic dysfunction: paradoxical worsening of liver enzymes in rare cases.
• Interstitial lung disease: extremely rare pulmonary inflammation reported.

When considering Legalon, several precautions should be observed to ensure safe use.

• Pregnancy: safety has not been established; use only if clearly needed and under medical supervision.
• Breastfeeding: avoid unless advised by a healthcare professional due to limited data.
• Drug interactions: review concomitant medications, especially anticoagulants and cytochrome P450 substrates.
• Liver monitoring: periodic liver function tests are recommended during prolonged therapy.
• Allergies: discontinue if signs of hypersensitivity such as rash or swelling appear.
• Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Legalon may influence the activity of other medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): may increase bleeding risk through additive antiplatelet effects.
• Hormonal contraceptives: potential reduction in efficacy due to enzyme induction.

Moderate Interactions (Monitor Closely)

• Cytochrome P450 substrates (e.g., statins, certain antidepressants): silymarin may alter metabolism, requiring dose adjustment.
• Immunosuppressants (e.g., cyclosporine): possible change in drug levels.
• Diabetes medications (e.g., sulfonylureas): may affect glucose control.
• Herbal supplements: concurrent use with other hepatoprotective herbs may increase risk of adverse effects.